The approximate amount of grB that might be needed to effectively target tumors in vivo was assessed by measuring the capacity of grB to induce apoptosis in 3D tumor spheroids on day 2 after incubation with 4, 10, 20, 40 and 80 μg/ml grB. The gene discussed is GZMB; the disease is neoplasm.